Sei Investments CO Alkermes Plc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Alkermes Plc. stock. As of the latest transaction made, Sei Investments CO holds 74,566 shares of ALKS stock, worth $2.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,566

Previous 74,157 0.55%

Holding current value

$2.18 Million

Previous $1.79 Million 16.79%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$23.01 - $28.55 $9,411 - $11,676	409 Added 0.55%	74,566 $2.09 Million
Q2 2024 Aug 13, 2024	SELL	$23.21 - $27.24 $87,849 - $103,103	-3,785 Reduced 4.86%	74,157 $1.79 Million
Q1 2024 May 07, 2024	BUY	$26.4 - $32.56 $189,499 - $233,715	7,178 Added 10.14%	77,942 $2.11 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $1,332 - $1,634	57 Added 0.08%	70,764 $1.96 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $39,776 - $46,804	1,464 Added 2.11%	70,707 $1.98 Million
Q2 2023 Aug 11, 2023	SELL	$28.34 - $33.63 $393,784 - $467,288	-13,895 Reduced 16.71%	69,243 $2.17 Million
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $177,752 - $203,807	7,023 Added 9.23%	83,138 $2.34 Million
Q4 2022 Feb 10, 2023	SELL	$21.94 - $26.24 $708,332 - $847,158	-32,285 Reduced 29.78%	76,115 $1.99 Million
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $244,860 - $354,713	-11,130 Reduced 9.31%	108,400 $2.42 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $1.43 Million - $1.66 Million	54,243 Added 83.08%	119,530 $3.56 Million
Q1 2022 May 13, 2022	BUY	$23.07 - $27.99 $93,525 - $113,471	4,054 Added 6.62%	65,287 $1.72 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $1.3 Million - $1.95 Million	-60,735 Reduced 49.8%	61,233 $1.42 Million
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $791,565 - $1.09 Million	33,871 Added 38.45%	121,968 $3.09 Million
Q2 2021 Aug 06, 2021	SELL	$18.78 - $25.15 $462,025 - $618,740	-24,602 Reduced 21.83%	88,097 $2.16 Million
Q1 2021 May 12, 2021	SELL	$18.21 - $23.2 $486,680 - $620,043	-26,726 Reduced 19.17%	112,699 $2.08 Million
Q4 2020 Feb 08, 2021	SELL	$15.39 - $22.1 $110,992 - $159,385	-7,212 Reduced 4.92%	139,425 $2.73 Million
Q3 2020 Dec 04, 2020	SELL	$16.16 - $20.66 $290,314 - $371,156	-17,965 Reduced 10.91%	146,637 $2.44 Million
Q3 2020 Nov 06, 2020	BUY	$16.16 - $20.66 $947,590 - $1.21 Million	58,638 Added 55.34%	164,602 $2.73 Million
Q2 2020 Aug 17, 2020	BUY	$13.31 - $19.41 $676,653 - $986,765	50,838 Added 92.22%	105,964 $2.03 Million
Q2 2020 Aug 11, 2020	BUY	$13.31 - $19.41 $219,029 - $319,410	16,456 Added 42.55%	55,126 $1.09 Million
Q1 2020 May 14, 2020	SELL	$13.06 - $21.24 $132,989 - $216,286	-10,183 Reduced 20.84%	38,670 $551,000
Q4 2019 Feb 06, 2020	SELL	$17.29 - $21.74 $911,961 - $1.15 Million	-52,745 Reduced 51.92%	48,853 $993,000
Q3 2019 Nov 12, 2019	SELL	$19.51 - $24.28 $29,518 - $36,735	-1,513 Reduced 1.47%	101,598 $1.98 Million
Q2 2019 Aug 14, 2019	SELL	$21.47 - $37.33 $622,200 - $1.08 Million	-28,980 Reduced 21.94%	103,111 $2.32 Million
Q1 2019 May 15, 2019	BUY	$28.4 - $36.49 $101,728 - $130,707	3,582 Added 2.79%	132,091 $4.82 Million
Q3 2018 Nov 08, 2018	BUY	$38.6 - $46.12 $37,094 - $44,321	961 Added 0.75%	128,509 $5.45 Million
Q2 2018 Aug 03, 2018	SELL	$40.56 - $51.36 $136,362 - $172,672	-3,362 Reduced 2.57%	127,548 $5.25 Million
Q1 2018 May 11, 2018	SELL	$53.61 - $67.26 $5.88 Million - $7.38 Million	-109,677 Reduced 45.59%	130,910 $7.59 Million
Q4 2017 Feb 08, 2018	BUY	$47.69 - $55.39 $3.97 Million - $4.61 Million	83,239 Added 52.9%	240,587 $13.2 Million
Q3 2017 Nov 06, 2017	BUY	$49.16 - $54.45 $7.74 Million - $8.57 Million	157,348	157,348 $8 Million

Others Institutions Holding ALKS

# of Institutions

363

Shares Held

182M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.8B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Alkermes Plc. Transaction History